The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Aims to boost speed & precision in patient care
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Subscribe To Our Newsletter & Stay Updated
